BR9508419A - Pharmaceutical compositions comprising a cholinergic tnf binding protein - Google Patents

Pharmaceutical compositions comprising a cholinergic tnf binding protein

Info

Publication number
BR9508419A
BR9508419A BR9508419A BR9508419A BR9508419A BR 9508419 A BR9508419 A BR 9508419A BR 9508419 A BR9508419 A BR 9508419A BR 9508419 A BR9508419 A BR 9508419A BR 9508419 A BR9508419 A BR 9508419A
Authority
BR
Brazil
Prior art keywords
cholinergic
pharmaceutical compositions
binding protein
tnf binding
tnf
Prior art date
Application number
BR9508419A
Other languages
Portuguese (pt)
Inventor
Robert Frederick Geoffre Booth
Werner Lesslauer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR9508419A publication Critical patent/BR9508419A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
BR9508419A 1994-07-22 1995-07-15 Pharmaceutical compositions comprising a cholinergic tnf binding protein BR9508419A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94111455 1994-07-22
PCT/EP1995/002788 WO1996003141A1 (en) 1994-07-22 1995-07-15 Pharmaceutical compositions comprising a chimaeric tnf binding protein

Publications (1)

Publication Number Publication Date
BR9508419A true BR9508419A (en) 1997-11-18

Family

ID=8216138

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9508419A BR9508419A (en) 1994-07-22 1995-07-15 Pharmaceutical compositions comprising a cholinergic tnf binding protein

Country Status (11)

Country Link
EP (1) EP0772449A1 (en)
JP (1) JPH09508140A (en)
AU (1) AU3111995A (en)
BR (1) BR9508419A (en)
CA (1) CA2195665A1 (en)
CZ (1) CZ283219B6 (en)
FI (1) FI970247A (en)
HU (1) HUT76666A (en)
NO (1) NO970264L (en)
PL (1) PL318501A1 (en)
WO (1) WO1996003141A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6350730B1 (en) 1994-08-17 2002-02-26 The Rockefeller University OB polypeptides and modified forms as modulators of body weight
US6471956B1 (en) 1994-08-17 2002-10-29 The Rockefeller University Ob polypeptides, modified forms and compositions thereto
US6001968A (en) 1994-08-17 1999-12-14 The Rockefeller University OB polypeptides, modified forms and compositions
US6429290B1 (en) 1994-08-17 2002-08-06 The Rockefeller University OB polypeptides, modified forms and derivatives
US20030040467A1 (en) 1998-06-15 2003-02-27 Mary Ann Pelleymounter Ig/ob fusions and uses thereof.
US6936439B2 (en) 1995-11-22 2005-08-30 Amgen Inc. OB fusion protein compositions and methods
CA2253557A1 (en) * 1996-05-08 1997-11-13 Louis Martin Renzetti Treatment of asthma with tnfr-ig
TW555765B (en) * 1996-07-09 2003-10-01 Amgen Inc Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
US7070771B1 (en) 1996-12-09 2006-07-04 Regents Of The University Of California Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells
JP2001526632A (en) * 1996-12-12 2001-12-18 ジェネンテク，インコーポレイテッド HVEM polypeptides and their uses
MXPA01005267A (en) 1998-11-27 2002-04-24 Synaptics Uk Ltd Position sensor.
MXPA03007563A (en) * 2001-02-23 2003-12-11 Immunex Corp Increased recovery of active proteins.
WO2003011323A1 (en) * 2001-07-30 2003-02-13 Genset S.A. Agonists and antagonists of contabix for use in the treatment of metabolic disorders
US7786282B2 (en) 2001-12-06 2010-08-31 The Regents Of The University Of California Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain
DK1471974T3 (en) 2002-02-06 2007-12-03 Ares Trading Sa Tumor necrosis factor combined with interferon in demyelinating diseases
NZ554520A (en) 2004-10-22 2010-03-26 Amgen Inc Methods for refolding of recombinant antibodies
US11111284B2 (en) 2014-08-21 2021-09-07 The General Hospital Corporation Tumor necrosis factor superfamily and TNF-like ligand muteins and methods of preparing

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL98078A0 (en) * 1991-05-07 1992-06-21 Yeda Res & Dev Pharmaceutical compositions comprising an anticytokyne
DE10399023I2 (en) * 1989-09-12 2006-11-23 Ahp Mfg B V TFN-binding proteins
GB9015908D0 (en) * 1990-07-19 1990-09-05 Celltech Ltd Multivalent immunoglobulin
EP0620739A4 (en) * 1992-09-15 1997-01-15 Immunex Corp Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists.
WO1994008609A1 (en) * 1992-10-15 1994-04-28 Dana-Farber Cancer Institute, Inc. TREATMENT OF INSULIN RESISTANCE IN OBESITY LINKED TYPE II DIABETES USING ANTAGONISTS TO TNF-α FUNCTION

Also Published As

Publication number Publication date
HUT76666A (en) 1997-10-28
CA2195665A1 (en) 1996-02-08
WO1996003141A1 (en) 1996-02-08
EP0772449A1 (en) 1997-05-14
NO970264L (en) 1997-03-24
CZ283219B6 (en) 1998-02-18
PL318501A1 (en) 1997-06-23
FI970247A0 (en) 1997-01-21
FI970247A (en) 1997-01-21
AU3111995A (en) 1996-02-22
CZ19397A3 (en) 1997-06-11
JPH09508140A (en) 1997-08-19
NO970264D0 (en) 1997-01-21

Similar Documents

Publication Publication Date Title
IS4706A (en) pharmaceutical compositions
NO20004345D0 (en) Pharmaceutical composition
FI965202A0 (en) Pharmaceutical roofing compositions
ID22891A (en) PHARMACEUTICAL COMPOSITION FOR PIPERIDINOALANOL-DECONGESTANT COMBINATIONS
ID18352A (en) PHARMACEUTICAL COMPOSITIONS
BR9508419A (en) Pharmaceutical compositions comprising a cholinergic tnf binding protein
FI955311A0 (en) Pharmaceutical composition base
EE9800400A (en) Pharmaceutical compositions containing diclofenac
EE9900260A (en) Pharmaceutical compositions for freeze-drying
BR9507768A (en) Pharmaceutical composition
LV11727A (en) Pharmaceutical composition
BR9711315A (en) Pharmaceutical composition containing 4-oxobutanoic acids
EE9900440A (en) Pharmaceutical compositions
PT941100E (en) PHARMACEUTICAL COMPOSITIONS
ID25857A (en) PHARMACEUTICAL COMPOSITION
ITMI942166A0 (en) PHARMACEUTICAL COMPOSITIONS MIORELAXANTS
FI973280A (en) Pharmaceutical composition
ITMI962628A0 (en) PHARMACEUTICAL COMPOSITION
FI962738A0 (en) Pharmaceutical compositions
BR9605777A (en) Pharmaceutical composition
NO994436D0 (en) Pharmaceutical compositions
NO964309D0 (en) Pharmaceutical composition
IT1272935B (en) PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYL-CISTEIN
SE9402924D0 (en) Novel pharmaceutical composition
KR960016881A (en) Pharmaceutical composition

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO NAO CUMPRIMENTO DO DESPACHO 8.6 NA RPI 1781 DE 22/02/2005.